SARS-CoV-2 Antibody Testing | Beckman Coulter
Products & Solutions
Back
Products & Solutions
Core Disciplines
Chemistry Immunoassay Hematology Urinalysis Microbiology Blood Banking Clinical Decision Support Protein Chemistry Service
Workflow & Informatics
Automation Systems DxA 5000 Total Lab Automation DxA 5000 Fit Automation System Advanced Informatics Remisol Advance Middleware Remote Services & Diagnostics
Solutions For
Antimicrobial Resistance Advantaged Workflows Pioneering Digital Hematology Neurology High Sensitivity Diagnostics Host Response to Infection Cardiovascular Disease IDBV Solutions Diabetes Diagnostics Drug Monitoring & Detection Sepsis
Support
Back
Support
Account Support
How to Create Your Account Create Account Manage Account Settings View All Account Support
Product Support
DxS Service In Vitro Diagnostic Regulation (IVDR) Manage My Technical Documents Search for Technical Documents Safety Data Sheets (SDS/MSDS) Search for Software Downloads Technical Documents Overview Manage My Regulatory Notifications Manage My Warranties & Agreements Request Instrument Support View Services Information View All Product Support Access Quality Assurance Programs
Ordering Support
Order Status & Tracking Track My Invoices View Return/RMA Policy Get Help with Orders View All Ordering Support
Resources
Back
Resources
Product Training
Browse Learning Lab › Learning Lab Login ›
Education & Research
Webinars Posters
Insights
Clinical Studies & Trends Case Studies Publications
Company
Back
Company
People & Culture
Overview Sustainability Meet Our Teams Inclusion & Belonging How We Work History and Innovation
Careers
Job Search › Programs & Grants Office Locations
News & Events
Awards & Recognition Newsroom Blog Events Calendar
Home / Solutions /

Fighting the coronavirus pandemic drives you. We are in this fight together.

We are committed to helping drive your efforts to eliminate coronavirus by delivering purposefully built laboratory solutions that may play a key role in helping people return to work, school and the new normal around the world.

We are grateful to the friends and family of Beckman Coulter associates around the world who are on the front-lines during the fight against COVID-19. We thank and celebrate our healthcare heroes.

Resources to help in navigating the SARS-Cov-2 virus crisis

The SARS-CoV-2 virus and the COVID-19 disease have turned our lives upside down. Watch these videos and access related resources which have been developed to help in understanding, and managing, the SARS-CoV-2 virus pandemic.
Video
Antibody Testing: IgG and IgM
Video
Antibody Testing: Spike Protein
View all our videos covering COVID-19

Latest Blog Articles

Medical Value of SARS-CoV-2 Spike Protein

Get high medical value with Access SARS-CoV-2 IgG assay as it detects antibodies against the virus spike protein.

The Need for Efficiency in SARS-CoV-2 Antibody Testing

Efficiency may be even more important for labs during this pandemic. Learn what features drive efficiency in COVID-19 testing.

SARS-CoV-2 Webinars

SARS CoV-2 by PCR Testing
 SARS CoV-2 by PCR Testing

CoVID-19-infections
COVID-19 Infections

Clinical Laboratory's Role in Diagnosing Sepsis in ICU and ER
Clinical Laboratory's Role in Diagnosing
Sepsis in ICU and ER

Additional Resources

Serological tests can play a critical role in the fight against COVID-19 by helping healthcare professionals to identify individuals who have overcome an infection in the past and have developed an immune response. 1
Stephen M. Hahn, M.D.
Commissioner of Food and Drugs
U.S. Food and Drug Administration

Serology test can help individuals who have been exposed to COVID-19

Infographic Testing for the coronavirus

The news is full of information about a variety of tests. Some tests diagnose COVID-19; others identify novel coronavirus antibodies in the blood and serum. Here is a quick look at what test to use when and their benefits.

Download

Read more

Frequently Asked Questions

Diagnostic and serology tests are complementary as one is used in infectious patients—mostly those with symptoms (diagnostic)—and one is used to determine immune response (antibody, or serology). The readily available serology tests are lateral flow assays. In general, lateral flow assays are qualitative, single-test assays. Our test is a high-throughput immunoassay laboratory test that can be integrated in an automated workflow, regardless of the size of the laboratory.
Serology tests like the Access SARS-CoV-2 IgG assay can detect if an individual has previously been exposed to the virus—even if they had no symptoms—and if the individual has potentially developed an immune response by creating antibodies to the virus.
The Access SARS-CoV-2 IgG assay is designed as a qualitative immunoassay.
The Access SARS-CoV-2 IgG assay may be run on Access 2, DxI 600, DxI 800, DxC 880i, DxC 860i, DxC 680i, DxC 660i and DxC 600i analyzers.
The purpose of the Access SARS-CoV-2 IgG assay is to determine if a patient was exposed to SARS-CoV-2 and has potentially developed an immune response to SARS-CoV-2. The recommended method to diagnose a COVID-19 infection is a molecular diagnostic PCR test based on the detection of the virus RNA, like the one developed by another Danaher company, Cepheid. Antibody assays play a critical role in:
  • - identifying individuals who previously had COVID-19
  • - tests are acceptable to be used in the manufacture of COVID-19 convalescent plasma
Focusing on a menu that matters, Beckman Coulter also offers emergency use authorized assays for IL-6, SARS-CoV-2 IgM and SARS-CoV-2 IgG II
The principle of the assay is to immobilize the virus antigens using magnetic particles to capture IgG antibodies in patient samples and reveal them using labeled anti-IgG antibodies.
A serum or plasma specimen may be used.
No, the Access SARS-CoV-2 IgG assay is a random-access assay. No batching and no special maintenance is necessary.
Please sign up for our coronavirus updates to receive the latest information as it’s made available.

1https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-serological-tests

2Ling Ni, Fang Ye, Meng-Li Cheng, Yu Feng, Yong-Qiang Deng, Hui Zhao, Peng Wei, Jiwan Ge, Mengting Gou, Xiaoli Li, Lin Sun, Tianshu Cao, Pengzhi Wang, Chao Zhou, Rongrong Zhang, Peng Liang, Han Guo, Xinquan Wang, Cheng-Feng Qin, Fang Chen, Chen Dong. “Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals” https://doi.org/10.1016/j.immuni.2020.04.023


Not all products and solutions mentioned on this page are available in all countries.

Products
Support
Company Newsletter
Beckman Coulter Life Sciences
Stay Connected
Products
Support
Company
Newsletter
Beckman Coulter Life Sciences
Stay Connected

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

 

© 2025 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners. Some products may not be available in your country or region. Please contact your Beckman Coulter sales representative or distributor for more information.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.